Ciprofol
- Generic Name
- Ciprofol
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
用于消化道内镜检查中的镇静、支气管镜检查中的镇静以及全身麻醉诱导。
- Associated Conditions
- -
- Associated Therapies
- -
Ciprofol Based on Total Intravenous Anesthesia During Pediatric Laparoscopic Surgery
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 86
- Registration Number
- NCT06735430
Effects of Ciprofol on Postoperative Delirium and Outcomes in Elderly Patients Undergoing Major Thoracic Surgery
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Wang Tianlong
- Target Recruit Count
- 214
- Registration Number
- NCT06674226
- Locations
- 🇨🇳
Xuanwu Hospital, Beijing, Beijing, China
The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- Subei People's Hospital of Jiangsu Province
- Target Recruit Count
- 376
- Registration Number
- NCT06617039
- Locations
- 🇨🇳
Subei People's Hospital of Jiangsu Province, Yangzhou, Jiangsu, China
Comparison of Efficacy and Safety Between Ciprofol and Remimazolam During Fiberoptic Bronchoscopy
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Anhui Provincial Hospital
- Target Recruit Count
- 190
- Registration Number
- NCT06531915
Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Xie Kangjie
- Target Recruit Count
- 36
- Registration Number
- NCT06425757
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejang, China
Ciprofol Versus Propofol in Patients Undergoing Painless Hysteroscopy
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Baoding First Central Hospital
- Target Recruit Count
- 188
- Registration Number
- NCT06413862
Ciprofol Versus Propofol for Tracheal Intubation in ICU
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06344949
Median Effective Dose of Ciprofol-Assisted Sedation for Elderly Patients Undergoing Knee Arthroplasty
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Second Hospital of Shanxi Medical University
- Target Recruit Count
- 70
- Registration Number
- NCT06293131
- Locations
- 🇨🇳
Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
the 95% Effective Dose of Ciprofol for Adjunctive Sedation Undergoing Knee Arthroplasty in Elderly People
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Second Hospital of Shanxi Medical University
- Target Recruit Count
- 70
- Registration Number
- NCT06293144
- Locations
- 🇨🇳
Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
The Effect of Ciprofol on Breathing Patterns, Respiratory Drive, and Inspiratory Effort in Mechanically Ventilated Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Capital Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT06287138
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath